Mitrokhin SD - Search Results

1

Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19.

Kombarova SY, Aleshkin AV, Novikova LI, Bochkareva SS, Zatevalov AM, Mekhtiev ER, Mizaeva TE, Basov AA, Borisova OY, Likhanskaya EI, Voropaeva EA, Urban YN, Mitrokhin SD, Shkoda AS, Gushchin VA, Sinyavin AE, Nikiforova MA, Lebedin YS, Karaulov AV. Kombarova SY, et al. Among authors: mitrokhin sd. Bull Exp Biol Med. 2022 Oct;173(6):734-739. doi: 10.1007/s10517-022-05620-1. Epub 2022 Nov 2. Bull Exp Biol Med. 2022. PMID: 36322302 Free PMC article.

2

Immune and microbiological disorders in women with infectious and inflammatory pathology of the cervix.

Omarova SM, Alieva AI, Isaeva RI, Akayeva FS, Mironov AY, Mitrokhin SD. Omarova SM, et al. Among authors: mitrokhin sd. Klin Lab Diagn. 2022 May 21;67(5):309-314. doi: 10.51620/0869-2084-2022-67-5-309-314. Klin Lab Diagn. 2022. PMID: 35613351 English.

3

[Peptide imunofan and moxifloxacin combined effects on toxigenic strain Clostridium difficile in vitro.].

Shvydkaya MG, Zatevalov AM, Mitrokhin SD, Dzhandarova DT, Mironov AY. Shvydkaya MG, et al. Among authors: mitrokhin sd. Klin Lab Diagn. 2020 Jul 20;65(8):516-520. doi: 10.18821/0869-2084-2020-65-8-516-520. Klin Lab Diagn. 2020. PMID: 32762196 Russian.

4

Emergence of Candida auris in Russia.

Barantsevich NE, Orlova OE, Shlyakhto EV, Johnson EM, Woodford N, Lass-Floerl C, Churkina IV, Mitrokhin SD, Shkoda AS, Barantsevich EP. Barantsevich NE, et al. Among authors: mitrokhin sd. J Hosp Infect. 2019 Aug;102(4):445-448. doi: 10.1016/j.jhin.2019.02.021. Epub 2019 Mar 6. J Hosp Infect. 2019. PMID: 30851375

5

[Microflora metabolites of different habitats in bronchopulmonary diseases].

Ardatskaia MD, Shevtsov VV, Zhakot AN, Fedankov IN, Mitrokhin SD, Mironov AIu, Ponomareva EV. Ardatskaia MD, et al. Among authors: mitrokhin sd. Eksp Klin Gastroenterol. 2014;(3):46-54. Eksp Klin Gastroenterol. 2014. PMID: 25518482 Russian.

6

[Adequate empiric therapy of nosocomial fungal infections in oncologic patients of intensive care units].

Mitrokhin SD, Fedankov IN, Khoteev AZh, Sokolov AA. Mitrokhin SD, et al. Antibiot Khimioter. 2012;57(3-4):40-4. Antibiot Khimioter. 2012. PMID: 22993939 Russian.

7

[Perspectives of tigecycline treatment of surgical site infections in oncologic patients].

Mitrokhin SD, Sokolov AA. Mitrokhin SD, et al. Antibiot Khimioter. 2012;57(3-4):33-9. Antibiot Khimioter. 2012. PMID: 22993938 Russian.

8

[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].

Mitrokhin SD, Sokolov AA. Mitrokhin SD, et al. Antibiot Khimioter. 2011;56(1-2):29-34. Antibiot Khimioter. 2011. PMID: 21780669 Clinical Trial. Russian.

9

[Amoxycillin/Sulbactam (Trifamox IBL) in prophylaxis and therapy of surgical site infections in oncologic patients].

Mitrokhin SD, Sokolov AA. Mitrokhin SD, et al. Antibiot Khimioter. 2010;55(7-8):34-41. Antibiot Khimioter. 2010. PMID: 21140563 Russian. No abstract available.

10

[Comparative study on the efficacy of cefuroxime, amoxycillin/clavulanic acid and fosfomycin in prophylaxis of nosocomial infections in oncologic patients after surgical operations].

Mitrokhin SD, Sokolov AA, Shirokograd VI, Zabaznyĭ NP. Mitrokhin SD, et al. Antibiot Khimioter. 2008;53(1-2):19-20, 22-4. Antibiot Khimioter. 2008. PMID: 18942388 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page